Skip to main content

Secondary diabetes

08-19-2021 | Pancreatitis | News

Postpancreatitis diabetes commonly misclassified and unsuitably treated

Postpancreatitis diabetes mellitus is under-recognized and often misclassified as type 2 diabetes, which can result in improper treatment, population-based study data show.

04-08-2020 | Ketoacidosis | News

DKA risk in secondary diabetes ‘could be underestimated’

Secondary diabetes may carry a higher risk for diabetic ketoacidosis than type 1 diabetes does, show findings from a population-based study.

04-27-2018 | Cystic fibrosis | News

HbA1c reflects blood glucose level in cystic fibrosis patients

Researchers have found that, contrary to received wisdom, glycated hemoglobin is an accurate guide to blood glucose levels in patients with cystic fibrosis.

12-04-2017 | Cystic fibrosis | News

Repaglinide equals insulin for glucose control in cystic-fibrosis-related diabetes

The oral antidiabetic drug repaglinide controls blood glucose levels as effectively as insulin in patients with newly diagnosed cystic-fibrosis-related diabetes, study findings indicate.

09-28-2016 | Pancreatitis | News | Article

Pancreatitis risk small but real with gliptin treatment

A meta-analysis of randomised trials indicates that gliptin treatment is associated with a small but significantly increased risk of acute pancreatitis among patients with Type 2 diabetes.